Table of Content

1. Market Guides

  • 1.1. COVID-19. Strategic Situation Analysis
    • 1.1.1. Covid Diagnostics-Market Shares of Major IVD Companies in 2021
  • 1.2. COVID-19. Guidance for Executives
  • 1.3. COVID-19. Guidance for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. What are Pandemics?
  • 2.2. The Role of Zoonosis
  • 2.3. Market Definition
    • 2.3.1. Assay Volumes.
    • 2.3.2. PCR
    • 2.3.3. PCR Multiplex
    • 2.3.4. SEQ
    • 2.3.5. Antigen
    • 2.3.6. Antibodies
    • 2.3.7. Instruments
    • 2.3.8. Reagents and Kits
    • 2.3.9. Extract
    • 2.3.10. Collect
    • 2.3.11. Public
    • 2.3.12. Hospital
    • 2.3.13. Clinic
    • 2.3.14. Workplace
    • 2.3.15. DTC/OTC
    • 2.3.16. Wastewater
  • 2.4. Methodology
    • 2.4.1. Authors
    • 2.4.2. Sources
  • 2.5. Historical Perspective on Pandemics
    • 2.5.1. HIV/AIDS PANDEMIC 2005-2012
    • 2.5.2. FLU PANDEMIC 1968
    • 2.5.3. ASIAN FLU 1956-1958
    • 2.5.4. SPANISH FLU 1918
    • 2.5.5. SIXTH CHOLERA PANDEMIC 1910-1911
    • 2.5.6. FLU PANDEMIC 1889-1890
    • 2.5.7. THE BLACK DEATH 1346-1353

3. The Pandemic Overview

  • 3.1. What is a Virus?
    • 3.1.1. Is a Virus Alive?
    • 3.1.2. Viral Structure
    • 3.1.3. The Viral Genome
    • 3.1.4. Viral Mutation
  • 3.2. The Coronavirus
    • 3.2.1. Severe acute respiratory syndrome (SARS)
    • 3.2.2. Middle East respiratory syndrome (MERS)
    • 3.2.3. COVID-19. The SARS CoV 2 Virus.
      • 3.2.3.1. Signs and symptoms
      • 3.2.3.2. Transmission
      • 3.2.3.3. Diagnosis
      • 3.2.3.4. Prevention
      • 3.2.3.5. Management
      • 3.2.3.6. Prognosis
      • 3.2.3.7. A Note on Global Statistics Reporting
  • 3.3. Pandemic Diagnostics
    • 3.3.1. Risk Management-Spark and Spread
    • 3.3.2. Dx Technology-Nucleic Acid Based
    • 3.3.3. Dx Technology-Immunoassay
    • 3.3.4. Time to Market and Preparedness Issues

4. Diagnostic Company Profiles

  • 4.1. Abacus Diagnostica
  • 4.2. Abbott Diagnostics
  • 4.3. Accelerate Diagnostics
  • 4.4. Acces Bio
  • 4.5. Advanced Biological Laboratories
  • 4.6. Agena Bioscience, Inc.
  • 4.7. Agilent/Dako
  • 4.8. Altona Diagnostics
  • 4.9. Alveo Technologies
  • 4.10. Anatolia Geneworks
  • 4.11. Applied BioCode
  • 4.12. Applied DNA Sciences
  • 4.13. Assurance Scientific Laboratories
  • 4.14. Aus Diagnostics
  • 4.15. Autobio Diagnostics
  • 4.16. Beckman Coulter Diagnostics
  • 4.17. Becton, Dickinson and Company
  • 4.18. BGI Genomics Co. Ltd.
  • 4.19. BillionToOne
  • 4.20. Binx Health
  • 4.21. Biocartis
  • 4.22. Biodesix Inc.
  • 4.23. BioFire Diagnostics (bioMérieux)
  • 4.24. Biolidics Ltd
  • 4.25. bioMérieux Diagnostics
  • 4.26. Bioneer Corporation
  • 4.27. Bio-Rad Laboratories, Inc
  • 4.28. Bio-Reference Laboratories
  • 4.29. Bosch Healthcare Solutions GmbH
  • 4.30. Cepheid (Danaher)
  • 4.31. Chembio
  • 4.32. Co Diagnostics
  • 4.33. Color Genomics
  • 4.34. Cue Health
  • 4.35. Curetis N.V. / Curetis GmbH
  • 4.36. Diagenode Diagnostics
  • 4.37. Diasorin S.p.A.
  • 4.38. Ellume
  • 4.39. Enzo Life Sciences, Inc.
  • 4.40. Everywell
  • 4.41. Fluxergy
  • 4.42. Fujirebio
  • 4.43. Fulgent Genetics
  • 4.44. Fusion Genomics.
  • 4.45. Genedrive
  • 4.46. Genetic Signatures
  • 4.47. GenMark Dx (Roche)
  • 4.48. Gold Standard Diagnostics
  • 4.49. Hologic
  • 4.50. Illumina
  • 4.51. Immunexpress
  • 4.52. Inflammatix
  • 4.53. Janssen Diagnostics
  • 4.54. Karius
  • 4.55. Laboratory Corporation of America
  • 4.56. Letsgetchecked
  • 4.57. Lexagene
  • 4.58. Luminex Corp
  • 4.59. LumiraDx
  • 4.60. Mammoth Biosciences
  • 4.61. Mayo Clinic Laboratories
  • 4.62. Mbio Diagnostics
  • 4.63. Meridian Bioscience
  • 4.64. Mesa Biotech (Thermo Fisher)
  • 4.65. Mobidiag (Hologic)
  • 4.66. Nanomix
  • 4.67. Novacyt
  • 4.68. OraSure Technologies
  • 4.69. Ortho Clinical Diagnostics
  • 4.70. Oxford Nanopore Technologies
  • 4.71. Perkin Elmer
  • 4.72. Primerdesign (Novacyt)
  • 4.73. Prominex
  • 4.74. Qiagen
  • 4.75. QuantuMDx
  • 4.76. Quest Diagnostics
  • 4.77. Quidel
  • 4.78. Randox Toxicology
  • 4.79. Roche Molecular Diagnostics
  • 4.80. SD Biosensor
  • 4.81. Seegene
  • 4.82. Sense Biodetection
  • 4.83. Sherlock Biosciences
  • 4.84. Siemens Healthineers
  • 4.85. Sona Nanotech
  • 4.86. SpeeDx
  • 4.87. Thermo Fisher Scientific Inc.
  • 4.88. Veredus Laboratories
  • 4.89. Vircell
  • 4.90. Visby Medical
  • 4.91. YD Diagnostics
  • 4.92. Zhejiang Orient Gene Biotech

5. Covid-19 Diagnostics Recent Developments

  • 5.1. Recent Developments-Importance and How to Use This Section
    • 5.1.1. Importance of These Developments
    • 5.1.2. How to Use This Section
  • 5.2. Becton Dickinson, ReturnSafe Collaborate on COVID-19 Testing
  • 5.3. Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA
  • 5.4. At-Home COVID Test Coverage
  • 5.5. LuminUltra Wins 500-Site CDC Wastewater Testing Contract
  • 5.6. Sense Biodetection to Debut Instrument-Free Point-of-Care MDx
  • 5.7. Tests Called Back
  • 5.8. Cepheid Obtains CE Mark for Expanded Combo COVID Test
  • 5.9. CRISPR Tests for SARS-CoV-2 Using Saliva Samples
  • 5.10. CVS Limits Purchases of Rapid Covid-19 Tests
  • 5.11. Illumina, COVID-19 Surveillance Continue to Boost Business
  • 5.12. LetsGetChecked Closes $150M Funding Round
  • 5.13. Novacyt Gets CE Mark for Multigene SARS-CoV-2 Test, Launches RUO Variant Assay
  • 5.14. Abbott Sees Sharp Decline in COVID-19 Test Revenue
  • 5.15. Phosphorus Diagnostics Gets EUA for DTC C19 Test, Sample Collection Kit
  • 5.16. NY Times Explores Multiplex Testing
  • 5.17. Hologic Banking on MDx Acquisitions
  • 5.18. Demand for Cepheid SARS-CoV-2 Point-of-Care Tests to Continue Through 2022
  • 5.19. DiaSorin Acquires Luminex to Broaden MDx Portfolio, Expand US Presence
  • 5.20. LumiraDx to Go Public Through SPAC
  • 5.21. Eurofins Test Helps to ID Mutations
  • 5.22. Roche Sees Growing Opportunities for Diagnostics
  • 5.23. Roche to Acquire GenMark Diagnostics for $1.8B
  • 5.24. Fulgent Genetics s to Use COVID-19 Testing Gains to Grow Clinical Sequencing
  • 5.25. LexaGene Syndromic Panel Platform Lets Labs Customize Targets
  • 5.26. FDA Grants EUAs for DTC Sample Collection Kit, Two Molecular Tests
  • 5.27. At-Home Infectious Disease Test Developer Lucira Health Goes Public

6. The Global Market for COVID-19 Diagnostics

  • 6.1. Global Market Overview by Country
    • 6.1.1. Table-Global Market by Country
    • 6.1.2. Chart-Global Market by Country
    • 6.1.3. Table-Global Market by Country-Assay Volumes
  • 6.2. Global Market by Technology-Overview
    • 6.2.1. Table-Global Market by Technology
    • 6.2.2. Chart-Global Market by Technology-Base/Final Year Comparison
    • 6.2.3. Chart-Global Market by Technology-Base Year
    • 6.2.4. Chart-Global Market by Technology-End Year
    • 6.2.5. Chart-Global Market by Technology-Share by Year
    • 6.2.6. Chart-Global Market by Technology-Segments Growth
  • 6.3. Global Market by Product-Overview
    • 6.3.1. Table-Global Market by Product
    • 6.3.2. Chart-Global Market by Product-Base/Final Year Comparison
    • 6.3.3. Chart-Global Market by Product-Base Year
    • 6.3.4. Chart-Global Market by Product-End Year
    • 6.3.5. Chart-Global Market by Product-Share by Year
    • 6.3.6. Chart-Global Market by Product-Segments Growth
  • 6.4. Global Market by Channel-Overview
    • 6.4.1. Table-Global Market by Channel
    • 6.4.2. Chart-Global Market by Channel-Base/Final Year Comparison
    • 6.4.3. Chart-Global Market by Channel-Base Year
    • 6.4.4. Chart-Global Market by Channel-End Year
    • 6.4.5. Chart-Global Market by Channel-Share by Year
    • 6.4.6. Chart-Global Market by Channel-Segments Growth

7. Global COVID-19 Diagnostic Markets-By Technology

  • 7.1. PCR
    • 7.1.1. Table PCR-by Country
    • 7.1.2. Chart-PCR Growth
  • 7.2. PCR Multiplex
    • 7.2.1. Table PCR Multiplex-by Country
    • 7.2.2. Chart-PCR Multiplex Growth
  • 7.3. Sequencing
    • 7.3.1. Table Sequencing-by Country
    • 7.3.2. Chart-Sequencing Growth
  • 7.4. Antibody
    • 7.4.1. Table Antibody-by Country
    • 7.4.2. Chart-Antibody Growth
  • 7.5. Antigen
    • 7.5.1. Table Antigen-by Country
    • 7.5.2. Chart-Antigen Growth

8. Global COVID-19 Diagnostic Markets-By Product

  • 8.1. Instruments
    • 8.1.1. Table Instruments-by Country
    • 8.1.2. Chart-Instruments Growth
  • 8.2. Reagents & Kits
    • 8.2.1. Table Reagents & Kits-by Country
    • 8.2.2. Chart-Reagents & Kits Growth
  • 8.3. Extraction
    • 8.3.1. Table Extraction-by Country
    • 8.3.2. Chart-Extraction Growth
  • 8.4. Collection
    • 8.4.1. Table Collection-by Country
    • 8.4.2. Chart-Collection Growth

9. Global COVID-19 Diagnostic Markets-By Channel

  • 9.1. Public
    • 9.1.1. Table Public-by Country
    • 9.1.2. Chart-Public Growth
  • 9.2. Hospital
    • 9.2.1. Table Hospital-by Country
    • 9.2.2. Chart-Hospital Growth
  • 9.3. Clinic
    • 9.3.1. Table Clinic-by Country
    • 9.3.2. Chart-Clinic Growth
  • 9.4. Workplace
    • 9.4.1. Table Workplace-by Country
    • 9.4.2. Chart-Workplace Growth
  • 9.5. DTC/OTC
    • 9.5.1. Table DTC/OTC-by Country
    • 9.5.2. Chart-DTC/OTC Growth
  • 9.6. Wastewater
    • 9.6.1. Table Wastewater-by Country
    • 9.6.2. Chart-Wastewater Growth

10. Appendix

  • 10.1. U.S., Europe, Asia Approved COVID-19 Assays

Table of Tables

  • Table 1: Who List of Potential Pandemic Pathogens
  • Table 2: Characteristics of Coronavirus Pandemic Infections
  • Table 3: COVID-19 Symptoms
  • Table 4: Global Market by Region
  • Table 5: Global Market Assay Volumes by Region
  • Table 6: Global Market by Technology
  • Table 7: Global Market by Product
  • Table 8: Global Market by Channel
  • Table 9: PCR by Country
  • Table 10: PCR Multiplex by Country
  • Table 11: Sequencing by Country
  • Table 12: Antibody by Country
  • Table 13: Antigen by Country
  • Table 14: Instruments by Country
  • Table 15: Reagents & Kits by Country
  • Table 16: Extraction by Country
  • Table 17: Collection by Country
  • Table 18: Public by Country
  • Table 19: Hospital by Country
  • Table 20: Clinic by Country
  • Table 21: Workplace by Country
  • Table 22: DTC/OTC by Country
  • Table 23: Wastewater by Country
  • Table 24: Approved Covid-19 Assays

Table of Figures

  • Figure 1: Global Covid-19 Dx-Market Shares of Major Players
  • Figure 2: Global Distribution Pandemic Preparedness
  • Figure 3: Global Pandemic Pathogen Status
  • Figure 4: Estimated Economic Impact of Viral Pandemic by Region
  • Figure 5: Historical Pandemics Infographic
  • Figure 6: Antigenic Drift Creates a new Strain of Virus
  • Figure 7: Structure of Coronaviruses
  • Figure 8: Global Market Share Chart
  • Figure 9: Base/Final Year Comparison Chart
  • Figure 10: Global Markets by Technology Base Year
  • Figure 11: Global Markets by Technology End Year
  • Figure 12: Global Markets by Technology Share by Year
  • Figure 13: Global Markets by Technology Segment Growth
  • Figure 14: Global Market by Product Base vs. Final
  • Figure 15: Global Market by Product Base Year
  • Figure 16: Global Market by Product End Year
  • Figure 17: Global Market by Product Share by Year
  • Figure 18: Global Market by Product Segments Growth
  • Figure 19: global Market by Channel-Base vs. Final
  • Figure 20: global Market by Channel-Base Year
  • Figure 21: global Market by Channel-End Year
  • Figure 22: global Market by Channel-Share by Year
  • Figure 23: global Market by Channel-Segments Growth
  • Figure 24: PCR Growth
  • Figure 25: PCR Multiplex Growth
  • Figure 26: Sequencing Growth
  • Figure 27: Antibody Growth
  • Figure 28: Antigen Growth
  • Figure 29: Instruments Growth
  • Figure 30: Reagents & Kits Growth
  • Figure 31: Extraction Growth
  • Figure 32: Collection Growth
  • Figure 33: Public Growth
  • Figure 34: Hospital Growth
  • Figure 35: Clinic Growth
  • Figure 36: Workplace Growth
  • Figure 37: DTC/OTC Growth
  • Figure 38: Wastewater Growth